Neogen (NASDAQ:NEOG) Hits New 1-Year High After Better-Than-Expected Earnings

Posted by on Aug 2nd, 2026

Neogen Corporation (NASDAQ:NEOG – Get Free Report)’s share price reached a new 52-week high during trading on Friday after the company announced better than expected quarterly earnings. The company traded as high as $11.56 and last traded at $11.53, with a volume of 4761033 shares. The stock had previously closed at $9.40.

The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.03. Neogen had a positive return on equity of 2.78% and a negative net margin of 0.91%.The company had revenue of $225.30 million during the quarter, compared to analyst estimates of $212.35 million. During the same period in the previous year, the company earned ($2.82) earnings per share. The company’s quarterly revenue was down .1% compared to the same quarter last year.

Key Headlines Impacting Neogen

Here are the key news stories impacting Neogen this week:

  • Positive Sentiment: Neogen reported fiscal Q4 adjusted earnings of $0.09 per share, above the $0.05 analyst consensus and substantially better than the $2.82-per-share loss reported in the year-ago quarter. Revenue of $225.3 million also exceeded estimates of $212.35 million. Neogen Beats Q4 Earnings and Revenue Estimates
  • Positive Sentiment: Management forecast fiscal 2027 revenue of $880 million to $885 million, above the $851.1 million consensus estimate. First-quarter fiscal 2027 revenue guidance of $207 million to $209 million also topped the $204.9 million consensus. Neogen Fiscal 2027 Guidance
  • Positive Sentiment: The company expects fiscal 2027 adjusted EBITDA of approximately $180 million to $182 million, signaling anticipated improvement in profitability and supporting the favorable investor reaction. Neogen Fiscal 2026 Results
  • Neutral Sentiment: Despite the earnings beat, quarterly revenue was essentially flat year over year, down 0.1%, indicating that the stronger outlook depends on future growth rather than current top-line acceleration.
  • Neutral Sentiment: Analysts’ average price target is approximately $10.67, below the stock’s recent trading level, suggesting valuation and expectations may limit additional upside. Analysts Set Neogen Price Target
  • Negative Sentiment: Neogen plans to increase research and development spending by roughly 50% in fiscal 2027. Although intended to support longer-term growth, the investment could pressure near-term margins and earnings.

Analysts Set New Price Targets

Several research firms recently commented on NEOG. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings lowered shares of Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, July 24th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $10.67.

Check Out Our Latest Analysis on Neogen

Institutional Trading of Neogen

A number of hedge funds have recently modified their holdings of the company. Huntington National Bank increased its position in shares of Neogen by 8.4% during the fourth quarter. Huntington National Bank now owns 13,552 shares of the company’s stock valued at $95,000 after purchasing an additional 1,045 shares during the period. ProShare Advisors LLC lifted its position in Neogen by 3.2% in the fourth quarter. ProShare Advisors LLC now owns 42,509 shares of the company’s stock worth $297,000 after purchasing an additional 1,331 shares during the period. State of Alaska Department of Revenue lifted its position in Neogen by 1.2% in the fourth quarter. State of Alaska Department of Revenue now owns 110,645 shares of the company’s stock worth $773,000 after purchasing an additional 1,353 shares during the period. Evergreen Capital Management LLC boosted its stake in Neogen by 12.3% during the fourth quarter. Evergreen Capital Management LLC now owns 13,753 shares of the company’s stock worth $96,000 after buying an additional 1,504 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV increased its holdings in Neogen by 10.1% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,837 shares of the company’s stock valued at $125,000 after buying an additional 1,638 shares during the period. Institutional investors own 96.73% of the company’s stock.

Neogen Trading Up 4.4%

The company has a market cap of $2.62 billion, a price-to-earnings ratio of -401.33, a PEG ratio of 5.39 and a beta of 1.80. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.84 and a current ratio of 3.82. The business’s 50 day moving average price is $9.44 and its 200-day moving average price is $9.62.

Neogen Company Profile

(Get Free Report)

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.

Featured Articles

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.